Definition of MART-1:27-35 peptide vaccine - National Cancer Institute Drug Dictionary

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate NCI Responds to Hurricanes The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

Search for

Starts with

Contains

All

MART-1:27-35 peptide vaccine
A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide. Check for or using this agent. ()

Previous:	marcellomycin, marijuana, marimastat, Marinol, MART-1 antigen
Next:	mast cell stabilizer TF002, Matulane, matuzumab, Maxidex, Maxipime